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1. BACKGROUND {#iwj13100-sec-0001}
=============

Venous leg ulcers and pressure ulcers are the most common types of complex, non‐traumatic skin ulcers, each with an estimated point prevalence of around 0.3% in the United Kingdom and between 0.05% and 1.52% in the United States.[1](#iwj13100-bib-0001){ref-type="ref"} Foot ulcers in people with diabetes are also relatively common, with a total UK point prevalence of 0.1%,[2](#iwj13100-bib-0002){ref-type="ref"} which amounts to a 5.5% prevalence in the UK diabetic population.[3](#iwj13100-bib-0003){ref-type="ref"} In North America, ulcer prevalence in the diabetic population is estimated to be 13%.[3](#iwj13100-bib-0003){ref-type="ref"}

Skin ulcers can be exceedingly painful and distressing for patients and can impair independence and health‐related quality of life.[4](#iwj13100-bib-0004){ref-type="ref"} The care of these complex ulcers is costly to health services, largely because of the volume of nursing time required. For example, in 2016, the annual cost for treating and managing pressure ulcers in the United Kingdom and the United States was estimated at approximately £2.6 billion[5](#iwj13100-bib-0005){ref-type="ref"} and \$9.1 to \$11.6 billion,[6](#iwj13100-bib-0006){ref-type="ref"} respectively; for foot ulcer in people with diabetes, estimates were £650 million[5](#iwj13100-bib-0005){ref-type="ref"}, [7](#iwj13100-bib-0007){ref-type="ref"} and \$9 to \$13 billion, respectively.[3](#iwj13100-bib-0003){ref-type="ref"}

Whilst many venous leg ulcers, pressure ulcers, and foot ulcers will heal, for some people, this will be protracted, with some never fully healing. A recent study of 247 people with venous leg ulcers reported that 62% of ulcers had healed within 24 weeks, with the other 38% remaining unhealed at the time of follow up.[8](#iwj13100-bib-0008){ref-type="ref"} Another study[9](#iwj13100-bib-0009){ref-type="ref"} on venous leg ulcers reported a median time to healing in three treatment arms of 84, 77, and 91 days. Studies in diabetic foot[10](#iwj13100-bib-0010){ref-type="ref"} and pressure ulcers[11](#iwj13100-bib-0011){ref-type="ref"} have reported a median healing time of 10 weeks.

Prognostic tools are used in several disease areas to identify patients at risk of a certain outcome and to aid clinical decisions or manage resources.[12](#iwj13100-bib-0012){ref-type="ref"} There is scope to use such tools to predict slow healing risk in those with common, non‐traumatic skin ulcers. Yet, there is no overarching intelligence about who is likely to heal and who is not, who may benefit from targeted healing‐oriented intervention and who will not, and whether we can use resources more efficiently by targeting those at highest risk.

Prognosis research is invaluable in providing ways to answer these questions. However, available tools only use ulcer characteristics (eg, ulcer size, tissue type) to predict healing time,[13](#iwj13100-bib-0013){ref-type="ref"} whereas others require variables that may be difficult to measure as part of regular ulcer assessments in practice (eg, ankle‐brachial pressure index).[14](#iwj13100-bib-0014){ref-type="ref"} To further improve these tools, we need robust evidence on what factors may have prognostic value for assessing the risk of delayed ulcer healing. Parker et al reviewed the literature up to 2013 in order to identify risk factors for delayed venous leg ulcer healing,[15](#iwj13100-bib-0015){ref-type="ref"} informing the subsequent development of a prognostic tool.[16](#iwj13100-bib-0016){ref-type="ref"} However, they applied a limited set of search terms related to prognostic factors, which was not in line with Cochrane guidance ([http://methods.cochrane.org/prognosis](http://methods.cochrane.org/prognosis))). Furthermore, it is unclear to what extent Parker\'s findings generalise to other ulcer types.

Therefore, we conducted a scoping review of the literature to gain insight into which factors may have potential prognostic value for delayed healing of several common non‐traumatic skin ulcer types, with a focus on factors that can be collected as part of routine ulcer assessments. We expect our findings to guide future decisions about what potential prognostic factors should be prioritised for further investigations through systematic reviews and meta‐analyses.

2. METHODS {#iwj13100-sec-0002}
==========

We designed and reported our scoping review guided by Arksey and O\'Malley\'s[17](#iwj13100-bib-0017){ref-type="ref"} framework, further recommendations by Levac et al[18](#iwj13100-bib-0018){ref-type="ref"} and the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses statement.[19](#iwj13100-bib-0019){ref-type="ref"}

2.1. Search strategy {#iwj13100-sec-0003}
--------------------

We searched Medline and Embase via Ovid for publications in English between 1997 and 2017. The search syntax consisted of terms related to the three ulcer types (informed by input from the Cochrane Wounds group, <http://wounds.cochrane.org>), combined with terms for prognosis, prognostic factors, and prediction models, as recommended by the Cochrane Prognosis Methods Group (<http://methods.cochrane.org/prognosis>); the full search syntax is available in Appendix [S1](#iwj13100-supitem-0001){ref-type="supplementary-material"}.

2.2. Study selection {#iwj13100-sec-0004}
--------------------

We assessed the eligibility of studies through a two‐stage screening process. Studies were eligible if they adhered to the following inclusion criteria:Conducted in an adult population with venous leg ulcers, diabetic foot ulcers, or pressure ulcers. These three non‐traumatic skin ulcers types were selected because of their high prevalence. Other less common ulcer types, such as vasculitic ulcers, were therefore excluded. Traumatic ulcers, such as those arising from surgery or damage to the skin caused by thermal or chemical means, were excluded because of the different aetiology and management of these ulcer types.Investigating ulcer healing as an outcome. We accepted authors\' definitions of ulcer healing and excluded studies that focused on other outcomes, such as ulcer infection or recurrence.Performed a statistical test on the relationship between individual, potential prognostic factors and ulcer healing as an outcome. We included results of clinical investigations as factors (eg, common blood and urine tests, ankle‐brachial pressure index, transcutaneous oxygenation saturation measurements) but excluded those for which measurement would be impractical in the context of routine ulcer assessments (eg, genetic factors). We also excluded papers that did not report significance levels for individual factors when evaluating a score or model combining multiple factors because this would make them ineligible for inclusion in future meta‐analyses.Designed as an observational cohort study. We excluded randomised controlled trials (RCTs) because they aim to determine the effect of treatment on ulcer healing while minimising the impact of other influencing factors, whereas these factors are the primary focus of our review. We did include studies that retrospectively used data from a single arm of a trial.Original studies, thereby excluding review articles and contributions to conference proceedings.

We first screened the titles and abstracts of all articles. Two authors (D.J. and S.M.) independently screened 50% of articles each and a random sample of 10% in duplicate. Any disagreement was solved through discussion. For all studies deemed relevant, the full text was reviewed using the same screening procedure as in the first stage.

2.3. Data extraction and synthesis {#iwj13100-sec-0005}
----------------------------------

We developed a structured form to aid extraction of items related to: general study characteristics (year of publication, country, study setting), study population (type of ulcer, sample size), length of follow up, if data collection was retrospective or prospective, and association between potential prognostic factors and the outcome (outcome definition, factors for which an association with the outcome had been tested \[ie, potential prognostic factors\], statistical method used). Data for all papers were extracted by one author (D.J.); data from a random sample of 20% of included studies were extracted independently by a second author (S.M.), with discrepancies solved through discussion.

Two researchers (S.V. and J.T., who is a clinician with experience of managing skin ulcers) independently reviewed all factors and categorised them as patient characteristics (eg, age, comorbidities, history of ulcers), ulcer characteristics and treatment (eg, size, depth, duration), or results from clinical investigations (eg, ankle‐brachial pressure index, serum albumin). Ulcer characteristics and treatment were defined as any observation, measurement, or treatment specific to the current ulcer site and immediate surrounding area. Clinical investigations included clinical measurements, clinical imaging, biochemical analysis of blood and urine, and microbiology results. Where needed, the same two researchers independently grouped similar factors into further subcategories to aid the synthesis of results, with discrepancies solved through discussion. For example, the "Patient characteristics" category included subcategories, such as "Socio‐economic status" (consisting of, eg, marital status, income, and educational attainment) and "Cardiovascular disease" (covering conditions such as congestive heart failure, peripheral arterial disease, and angina).

In order to identify potential prognostic factors that may warrant a systematic review, we selected factors that had been investigated by at least 10 studies and, for these factors, assessed if they had been defined in ways that were comparable across studies.

3. RESULTS {#iwj13100-sec-0006}
==========

The search yielded 6798 unique studies. We reviewed the full text of 72 studies, of which 42 were included. The most common reason for exclusion was that studies did not report ulcer healing as an outcome. Figure [1](#iwj13100-fig-0001){ref-type="fig"} shows the flow chart for study selection.

![Flow diagram for the identification of relevant studies](IWJ-16-800-g001){#iwj13100-fig-0001}

3.1. Characteristics of included studies {#iwj13100-sec-0007}
----------------------------------------

Table [1](#iwj13100-tbl-0001){ref-type="table"} displays the characteristics of included studies. Of the 42 studies included, 16 had been conducted in the United States, and for all three ulcer types, this was the most common country of origin. Most studies took place in an outpatient (26/42) or inpatient (8/42) setting; one study included patients from both.[32](#iwj13100-bib-0032){ref-type="ref"} Studies in community settings (2/42) and nursing homes (2/42) were less common.

###### 

Characteristics of included studies

  Reference                                                        Publication year   Country                            Setting                         Wound type   Sample size                                 Maximum follow up                              Data collection   Outcome                                                     Statistical methods[a](#iwj13100-note-0002){ref-type="fn"}
  ---------------------------------------------------------------- ------------------ ---------------------------------- ------------------------------- ------------ ------------------------------------------- ---------------------------------------------- ----------------- ----------------------------------------------------------- ------------------------------------------------------------
  Abbade et al[20](#iwj13100-bib-0020){ref-type="ref"}             2011               Brazil                             Outpatient                      VLU          90                                          \>10 years                                     NR                Ulcer not healed after \>10 years                           *t* test and regression
  Barwell et al[21](#iwj13100-bib-0021){ref-type="ref"}            2000               United Kingdom                     Community                       VLU          587                                         24 wk                                          Prospective       Time to healing                                             Cox regression
  Beckert et al[22](#iwj13100-bib-0022){ref-type="ref"}            2006               Germany                            Outpatient                      DFU          1000                                        1 year                                         Prospective       Time to healing                                             Cox regression
  Berlowitz et al[23](#iwj13100-bib-0023){ref-type="ref"}          1998               United States                      Nursing homes                   PU           819                                         6 mo                                           Retrospective     Healed at follow‐up                                         *t* test and regression
  Cardinal et al[24](#iwj13100-bib-0024){ref-type="ref"}           2009               United States                      NR                              VLU          338                                         12 wk                                          Retrospective     100% closure                                                Regression
  Chaby et al[25](#iwj13100-bib-0025){ref-type="ref"}              2013               France                             Outpatient                      VLU          104                                         24 wk                                          Prospective       Healed at follow‐up                                         Regression
  Christman et al[26](#iwj13100-bib-0026){ref-type="ref"}          2011               United States                      Outpatient                      DFU          183                                         "Patient‐specific"                             Retrospective     Wound area change per day                                   Regression
  Gohel et al[27](#iwj13100-bib-0027){ref-type="ref"}              2005               United Kingdom                     Outpatient                      VLU          1186                                        24 wk                                          Prospective       Healed at follow‐up                                         Cox regression
  Hjerppe et al[28](#iwj13100-bib-0028){ref-type="ref"}            2010               Finland                            Outpatient                      VLU          50                                          12 wk                                          Prospective       Healed at follow‐up                                         *χ* ^2^ tests
  Horn et al[29](#iwj13100-bib-0029){ref-type="ref"}               2015               United States                      Outpatient                      PU           NR[b](#iwj13100-note-0003){ref-type="fn"}   NR                                             Retrospective     Healed at follow‐up                                         *t* test and regression
  Ince et al[30](#iwj13100-bib-0030){ref-type="ref"}               2007               United Kingdom                     Outpatient                      DFU          449                                         1 year                                         Prospective       Time to healing                                             Cox regression
  Jemec[31](#iwj13100-bib-0031){ref-type="ref"}                    1999               Denmark                            Outpatient clinic               VLU          79                                          18 mo[c](#iwj13100-note-0004){ref-type="fn"}   Prospective       Wound size and healed                                       *χ* ^2^ tests and regression
  Jones and Fennie[32](#iwj13100-bib-0032){ref-type="ref"}         2007               United States                      Inpatient and outpatient        PU           114                                         6 mo                                           Retrospective     Healed at follow up                                         *t* test
  Kantor and Margolis[33](#iwj13100-bib-0033){ref-type="ref"}      1999               United States                      NR                              VLU          104                                         24 wk                                          Retrospective     Healed at follow up                                         Wilcoxon rank sum
  Kapoor et al[34](#iwj13100-bib-0034){ref-type="ref"}             2008               United States                      Nursing homes                   PU           2666                                        90 d                                           Retrospective     Healed at follow up                                         Regression
  Labropoulos et al[35](#iwj13100-bib-0035){ref-type="ref"}        2011               United States                      NR                              VLU          127                                         6 mo                                           Prospective       Not‐healed by 6 mo                                          *t* test
  Margolis et al[36](#iwj13100-bib-0036){ref-type="ref"}           2003               United States                      Outpatient                      DFU          19 280                                      20 wk                                          Retrospective     Healed at follow up                                         Regression
  Margolis et al[37](#iwj13100-bib-0037){ref-type="ref"}           1999               United States                      Outpatient                      VLU          260                                         24 wk                                          Retrospective     Healed at follow up                                         Regression
  McGinnis et al[38](#iwj13100-bib-0038){ref-type="ref"}           2013               United Kingdom                     Outpatient                      PU           140                                         2 years                                        Prospective       Time to healing                                             Cox regression
  Meaume et al[39](#iwj13100-bib-0039){ref-type="ref"}             2005               France                             Outpatient                      VLU          330                                         6 wk                                           Prospective       Area reduction of \>40%                                     Regression
  Moffatt et al[40](#iwj13100-bib-0040){ref-type="ref"}            2009               United Kingdom                     Inpatient and outpatient        VLU          113                                         48 wk                                          Prospective       Time to healing                                             Cox regression
  Monami et al[41](#iwj13100-bib-0041){ref-type="ref"}             2008               Italy                              Inpatient                       DFU          80                                          6 mo                                           Prospective       Healed                                                      *t* test and cox regression
  Oyibo et al[42](#iwj13100-bib-0042){ref-type="ref"}              2000               United Kingdom and United States   Outpatient                      DFU          194                                         18 mo                                          Prospective       Area and time to healed                                     Correlation and cox regression
  Park[43](#iwj13100-bib-0043){ref-type="ref"}                     2014               Korea                              Inpatient critical care         PU           155                                         1 year                                         Retrospective     Healed                                                      *t* test and regression
  Parker et al[44](#iwj13100-bib-0044){ref-type="ref"}             2016               Australia                          Outpatient                      VLU          247                                         24 wk                                          Retrospective     Healed at follow up                                         *t* test and regression
  Rhou et al[45](#iwj13100-bib-0045){ref-type="ref"}               2015               Australia                          Outpatient                      DFU          107                                         12 wk                                          Retrospective     Healing rate and healed at follow up                        *t* test and regression
  Ribu et al[46](#iwj13100-bib-0046){ref-type="ref"}               2008               Oslo, Norway                       Outpatient                      DFU          99                                          12 mo                                          Prospective       Healed at follow up                                         *t* test and [anova]{.smallcaps}
  Scotton et al[47](#iwj13100-bib-0047){ref-type="ref"}            2014               Finland                            Outpatient                      VLU          94                                          \>1 year                                       Retrospective     \>50% reduction at 6 and 12 mo                              Regression
  Snyder et al[48](#iwj13100-bib-0048){ref-type="ref"}             2010               United States                      Outpatient                      DFU          250                                         12 wk                                          Retrospective     Wound closure                                               *t* test
  Sung and Park[49](#iwj13100-bib-0049){ref-type="ref"}            2011               Korea                              Inpatient critical care         PU           158                                         NR                                             Retrospective     PUSH scale healing[d](#iwj13100-note-0005){ref-type="fn"}   *t* test and regression
  Takahashi et al[50](#iwj13100-bib-0050){ref-type="ref"}          2009               United States                      Wound service in primary care   PU           440                                         6 mo                                           Retrospective     Healed at follow up                                         Regression
  Taylor et al[51](#iwj13100-bib-0051){ref-type="ref"}             2002               United Kingdom                     Outpatient                      VLU          325                                         104 wk                                         Retrospective     Time to healed                                              Cox regression
  Vedhara et al[52](#iwj13100-bib-0052){ref-type="ref"}            2010               United Kingdom                     Outpatient                      DFU          93                                          24 wk                                          Prospective       Healed at follow up                                         Regression
  Wallenstein and Brem[53](#iwj13100-bib-0053){ref-type="ref"}     2004               United States                      Inpatient                       PU           45                                          12 wk                                          Prospective       Wound size, time until closure, and % reduction             Gompertz model[e](#iwj13100-note-0006){ref-type="fn"}
  Wang et al[54](#iwj13100-bib-0054){ref-type="ref"}               2014               China                              Inpatient                       DFU          194                                         1 year                                         Retrospective     Healed at follow up                                         *t* test and regression
  Warriner et al[55](#iwj13100-bib-0055){ref-type="ref"}           2011               United States                      NR                              DFU          120                                         12 wk                                          Retrospective     Healed at follow up                                         Fisher test
  Wielen et al[56](#iwj13100-bib-0056){ref-type="ref"}             2016               Switzerland                        Inpatient                       PU           55                                          Hospital length of stay                        Prospective       Time until closure                                          *t* test
  Wipke‐Tevis and Stotts[19](#iwj13100-bib-0019){ref-type="ref"}   1998               United States                      Inpatient                       VLU          25                                          4 wk                                           Prospective       Wound‐healing rate                                          Correlation and contingency
  Yang et al[57](#iwj13100-bib-0057){ref-type="ref"}               2016               Canada                             Outpatient                      VLU          522                                         1 year                                         Retrospective     Healed at follow up                                         Regression
  Yotsu et al[58](#iwj13100-bib-0058){ref-type="ref"}              2014               Japan                              Inpatient                       DFU          84                                          NR                                             Prospective       Healed                                                      *t* test and [anova]{.smallcaps}
  Zimny and Pfohl[59](#iwj13100-bib-0059){ref-type="ref"}          2005               Germany                            Outpatient                      DFU          41                                          \>10 wk                                        Prospective       Healing time and wound area                                 Correlation
  Zimny et al[10](#iwj13100-bib-0010){ref-type="ref"}              2002               Germany                            Outpatient                      DFU          31                                          25 wk                                          Prospective       Healing time and wound area reduction                       Correlation and regression

Abbreviations: [anova]{.smallcaps}, analysis of variance; DFU, diabetic foot ulcer; NR, not reported; PU, pressure ulcer; PUSH, pressure ulcer score for healing; VLU, venous leg ulcer.

Statistical method/test performed to determine if factors were associated with healing.

Patient numbers not reported, but paper reported 7349 body pressure ulcers and 2112 heel pressure ulcers.

Mean follow up.

PUSH which uses a score from 0 to 10 based on ulcer characteristics.

Univariate time series model considering the relationship between an outcome and time (eg, area‐time relationship).

Of the three ulcer types, venous leg ulcers were considered in 17 of 42 of the studies, foot ulcers in 15 of 42, and pressure ulcers in 10 of 42. Sample sizes (ie, participants recruited) ranged from 25[19](#iwj13100-bib-0019){ref-type="ref"} to 19 280,[36](#iwj13100-bib-0036){ref-type="ref"} with a median of 155 across studies. The majority of studies included fewer than 1000 patients (38/42). The maximum follow‐up period was reported in 35 studies and ranged from 4 weeks[19](#iwj13100-bib-0019){ref-type="ref"} to greater than 10 years,[20](#iwj13100-bib-0020){ref-type="ref"} with a median follow up of 24 weeks. Most studies (38/42) had a follow up of a year or less, with only one study[20](#iwj13100-bib-0020){ref-type="ref"} reporting a follow up longer than 2 years. In two studies, follow up depended on length of hospital stay[26](#iwj13100-bib-0026){ref-type="ref"} or time to the next clinic visit.[49](#iwj13100-bib-0049){ref-type="ref"}

Most studies (24/42) defined ulcer healing as a dichotomous outcome indicating whether the ulcer had healed (yes/no); another 10 used time to complete healing. Other definitions were: percentage of ulcer area reduction[39](#iwj13100-bib-0039){ref-type="ref"}, [47](#iwj13100-bib-0047){ref-type="ref"}; healing rate[19](#iwj13100-bib-0019){ref-type="ref"}; and the pressure ulcer scale for healing score,[49](#iwj13100-bib-0049){ref-type="ref"} which comprises of sub‐scores for ulcer size, tissue type, and exudate. Four studies considered more than one definition.[10](#iwj13100-bib-0010){ref-type="ref"}, [45](#iwj13100-bib-0045){ref-type="ref"}, [53](#iwj13100-bib-0053){ref-type="ref"}, [59](#iwj13100-bib-0059){ref-type="ref"} Overall, almost half of the studies (20/42) were prospective, but only three investigated pressure ulcer healing.[38](#iwj13100-bib-0038){ref-type="ref"}, [53](#iwj13100-bib-0053){ref-type="ref"}, [56](#iwj13100-bib-0056){ref-type="ref"} The most common statistical method used to analyse the data was regression analysis (30/42), and this was Cox regression in nine cases. *t* tests were the second most used statistical analysis performed and was used in 15 studies, some of which also used regression.

3.2. Potential prognostic factors {#iwj13100-sec-0008}
---------------------------------

Table [2](#iwj13100-tbl-0002){ref-type="table"} shows the result of the categorisation of potential prognostic factors for which studies investigated the association with ulcer healing; see Appendix [S2](#iwj13100-supitem-0002){ref-type="supplementary-material"} for the factors as originally reported by the authors of the studies. The number of factors investigated in individual studies ranged from 2 to 45 (median, 15). Factors regarded patient characteristics, ulcer characteristics, or results of clinical investigation in 35 of 42, 37 of 42 and 23 of 42 studies, respectively. Six studies investigated the prognostic value of factors related to only one category, whereas 14 investigated an association with ulcer healing for factors pertaining to two categories, and 22 investigated potential factors related to all three categories.

###### 

Factors investigated in each included study as potential prognostic factors for ulcer healing; \[number\] reflects the number of individual factors assigned to that subcategory in case there was more than 1

  Reference                                                        Total no. of factors investigated   Potential prognostic factors                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  ---------------------------------------------------------------- ----------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Diabetic foot ulcers (15 studies)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Beckert et al[22](#iwj13100-bib-0022){ref-type="ref"}            4                                   Local physical manifestations of poor vessel quality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Depth, location, no. of ulcers                                                                                     
  Christman et al[26](#iwj13100-bib-0026){ref-type="ref"}          15                                  Age, blood pressure \[2\], BMI, body temperature, cardiovascular disease, ethnicity, gender, neuropathy, pulse, smoking status                                                                                                                                                                                                                                                                                                                                                                                                                                                    No. of ulcers                                                                                                      Glycaemic control, inflammatory markers, lipid profile
  Ince et al[30](#iwj13100-bib-0030){ref-type="ref"}               12                                  Age, cardiovascular disease, diabetes \[2\], gender, non ulcer infection, socio‐economic status \[2\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Area, depth, location, time to assessment                                                                          
  Margolis et al[36](#iwj13100-bib-0036){ref-type="ref"}           7                                   Age, gender                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Area, duration, no. of ulcers, response to treatment, severity                                                     
  Monami et al[41](#iwj13100-bib-0041){ref-type="ref"}             8                                   Depression, other comorbidities and health issues, smoking status                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Area, duration, severity                                                                                           Glycaemic control, quality of vessels
  Oyibo et al[42](#iwj13100-bib-0042){ref-type="ref"}              9                                   Age, diabetes \[2\], gender                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Area, depth, location, ulcer infection                                                                             Quality of vessels
  Rhou et al[45](#iwj13100-bib-0045){ref-type="ref"}               26                                  Age, alcohol consumption, antibiotics use, cardiovascular disease \[2\], diabetes, gender, kidney disease, medications as proxy for comorbidities/other health issues \[5\], smoking status                                                                                                                                                                                                                                                                                                                                                                                       Area, depth, ulcer infection                                                                                       Alkaline phosphatase, glycaemic control, liver profile \[4\], renal function, serum albumin/total protein, urate
  Ribu et al[46](#iwj13100-bib-0046){ref-type="ref"}               10                                  Cognitive status and mental health, Cognitive status and mental health \[2\], Functional status \[3\], Overall health \[3\], Pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Snyder et al[48](#iwj13100-bib-0048){ref-type="ref"}             2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Area, response to treatment                                                                                        
  Vedhara et al[52](#iwj13100-bib-0052){ref-type="ref"}            21                                  Age, BMI, cancer, cardiovascular disease \[2\], cognitive status and mental health, depression, diabetes, gender, history of previous ulcers, hypertension, musculoskeletal disease, neuropathy, other comorbidities and health issues, smoking status, socio‐economic status \[2\]                                                                                                                                                                                                                                                                                               Area, ulcer infection                                                                                              Glycaemic control, quality of vessels (imaging)
  Wang et al[54](#iwj13100-bib-0054){ref-type="ref"}               32                                  Age, blood pressure \[2\], cardiovascular disease, diabetes \[3\], gender, history of previous ulcers, neuropathy, smoking status, socio‐economic status                                                                                                                                                                                                                                                                                                                                                                                                                          Area, duration, location, severity                                                                                 Glycaemic control \[2\], inflammatory markers \[2\], lipid profile, positive microbiology, quality of vessels \[2\], renal function \[3\], serum albumin/total protein \[2\], serum haemoglobin, thyroid function, urine albumin
  Warriner et al[55](#iwj13100-bib-0055){ref-type="ref"}           3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Area \[3\]                                                                                                         
  Yotsu et al[58](#iwj13100-bib-0058){ref-type="ref"}              19                                  Age, diabetes, gender, history of previous ulcers, kidney disease, other comorbidities and health issues                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Area \[2\], location, necrosis, no. of ulcers, severity, ulcer infection                                           Quality of vessels \[3\], renal function, serum albumin/total protein, serum haemoglobin
  Zimny and Pfohl[59](#iwj13100-bib-0059){ref-type="ref"}          2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Area \[2\]                                                                                                         
  Zimny et al[10](#iwj13100-bib-0010){ref-type="ref"}              2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Area \[2\]                                                                                                         
  Pressure ulcers (10 studies)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Berlowitz et al[23](#iwj13100-bib-0023){ref-type="ref"}          19                                  Age, functional status \[2\], gender, hospital admission, immobility \[5\], incontinence, kidney disease, medications as proxy for comorbidities/other health issues, non ulcer infection, other comorbidities and health issues, socio‐economic status, terminal illness                                                                                                                                                                                                                                                                                                         Ulcer type/aetiology                                                                                               
  Horn et al[29](#iwj13100-bib-0029){ref-type="ref"}               45                                  Age, autoimmune disease \[3\], BMI, Braden score, cardiovascular disease \[2\], cognitive status and mental health, diabetes \[2\], history of previous ulcers, gender, hospital admission, immobility \[3\], incontinence, kidney disease \[4\], liver dysfunction, medications as proxy for comorbidities/other health issues \[2\], medications negatively affecting ulcer healing, musculoskeletal disease, non‐traumatic amputation, nutrition \[2\], other comorbidities and health issues \[4\], smoking status, socio‐economic status, transplantation, transplantation   Area, duration \[2\], location, severity, ulcer infection                                                          Quality of vessels (imaging)
  Jones and Fennie[32](#iwj13100-bib-0032){ref-type="ref"}         41                                  Age, BMI, cancer, cardiovascular disease \[2\], cognitive status and mental health, depression, diabetes, DVT, electrolyte imbalance, ethnicity, gender, history of previous ulcers, hypertension, insurance, Kidney disease, musculoskeletal disease, neuropathy \[2\], nutrition, other comorbidities and health issues \[6\], smoking status, socio‐economic status \[2\], stroke, total number of comorbidities                                                                                                                                                               Area\[2\], depth, exudate \[2\], location, necrosis, no. of ulcers \[2\], severity \[2\]                           
  Kapoor et al[34](#iwj13100-bib-0034){ref-type="ref"}             11                                  Age, gender, history of previous ulcers, immobility \[3\], incontinence \[2\], terminal illness                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Severity \[2\]                                                                                                     
  McGinnis et al[38](#iwj13100-bib-0038){ref-type="ref"}           17                                  Age, Braden score, cardiovascular disease, ethnicity, gender, hospital admission, medications as proxy for comorbidities/other health issues, neuropathy, nutrition, other comorbidities and health issues, pain, smoking status                                                                                                                                                                                                                                                                                                                                                  Area, duration, severity, surrounding skin condition, tissue type                                                  
  Park[43](#iwj13100-bib-0043){ref-type="ref"}                     30                                  Age, blood pressure, Braden score, cancer, cardiovascular disease \[2\], diabetes, gender, history of previous ulcers, hypertension, immobility, incontinence, medications as proxy for comorbidities/other health issues, medications negatively affecting ulcer healing, musculoskeletal disease, nutrition \[2\], other comorbidities and health issues \[4\], smoking status, stool form                                                                                                                                                                                      Area, exudate, location, tissue type, ulcer infection                                                              Serum albumin/total protein, serum haemoglobin
  Sung and Park[49](#iwj13100-bib-0049){ref-type="ref"}            30                                  Age, blood pressure, Braden score, cancer, cardiovascular disease, cardiovascular disease, diabetes, gender, history of previous ulcers, hypertension, immobility, incontinence, medications as proxy for comorbidities/other health issues, medications negatively affecting ulcer healing, musculoskeletal disease, nutrition, nutrition, other comorbidities and health issues \[4\], smoking status, stool form                                                                                                                                                               Area, exudate, location, tissue type, ulcer infection                                                              Serum haemoglobin, serum albumin/total Protein
  Takahashi et al[50](#iwj13100-bib-0050){ref-type="ref"}          23                                  Age, BMI, cancer, cardiovascular disease \[3\], diabetes, gender, kidney disease, musculoskeletal disease \[2\], neuropathy, other comorbidities and health issues \[4\], stroke                                                                                                                                                                                                                                                                                                                                                                                                  Area, no. of ulcers                                                                                                Glycaemic control, inflammatory markers, quality of vessels, renal function
  Wallenstein and Brem[53](#iwj13100-bib-0053){ref-type="ref"}     1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Area                                                                                                               
  Wielen et al[56](#iwj13100-bib-0056){ref-type="ref"}             10                                  Age, gender, hospital admission, trauma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Duration, location, severity \[2\], ulcer status, ulcer type/aetiology                                             
  Venous leg ulcers (17 studies)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Abbade et al[20](#iwj13100-bib-0020){ref-type="ref"}             19                                  Age, BMI, diabetes, DVT, gender, history of previous ulcers, hypertension, local physical manifestations of poor vessel quality \[2\], multiparity                                                                                                                                                                                                                                                                                                                                                                                                                                Area                                                                                                               Quality of vessels \[8\]
  Barwell et al[21](#iwj13100-bib-0021){ref-type="ref"}            12                                  Age, diabetes, gender, immobility, musculoskeletal disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Area, duration                                                                                                     Quality of vessels \[5\]
  Chaby et al[25](#iwj13100-bib-0025){ref-type="ref"}              41                                  Age, BMI, cardiovascular disease \[2\], cognitive status and mental health \[3\], depression, DVT, functional status \[2\], gender, history of previous ulcers, insurance \[2\], kidney disease, local physical manifestations of poor vessel quality \[2\], musculoskeletal disease \[3\], other comorbidities and health issues, pain, prior venous surgery, socio‐economic status \[8\]                                                                                                                                                                                        Area \[2\], duration, response to treatment                                                                        Quality of vessels \[3\], serum albumin/total protein, serum haemoglobin
  Cardinal et al[24](#iwj13100-bib-0024){ref-type="ref"}           33                                  Age, alcohol consumption, BMI \[3\], cardiovascular disease \[2\], diabetes, DVT, gender, history of previous ulcers, hypertension, immobility, local physical manifestations of poor vessel quality \[4\], musculoskeletal disease \[2\], other comorbidities and health issues, pain, smoking status, stroke                                                                                                                                                                                                                                                                    Area \[2\], duration, exudate, location, necrosis, no. of ulcers, oedema, response to treatment                    Quality of vessels
  Gohel et al[27](#iwj13100-bib-0027){ref-type="ref"}              12                                  Age, diabetes, DVT, gender, musculoskeletal disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Duration, location                                                                                                 Quality of vessels \[5\]
  Hjerppe et al[28](#iwj13100-bib-0028){ref-type="ref"}            14                                  Age, BMI, diabetes, gender, immobility, medications as proxy for comorbidities/other health issues, smoking status                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Quality of vessels \[7\]
  Jemec[31](#iwj13100-bib-0031){ref-type="ref"}                    13                                  Age                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Area, duration                                                                                                     Alkaline phosphatase, electrolytes \[2\], glycaemic control, inflammatory markers, liver profile, quality of vessels, renal function, serum albumin/total protein, serum haemoglobin
  Kantor and Margolis[33](#iwj13100-bib-0033){ref-type="ref"}      5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Area \[5\]                                                                                                         
  Labropoulos et al[35](#iwj13100-bib-0035){ref-type="ref"}        6                                   Age, BMI, DVT \[3\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Area                                                                                                               
  Margolis et al[37](#iwj13100-bib-0037){ref-type="ref"}           26                                  Age, cardiovascular disease \[2\], diabetes, DVT, ethnicity, gender, hypertension, immobility, insurance, local physical manifestations of poor vessel quality \[3\], musculoskeletal disease, oedema, other comorbidities and health issues, stroke                                                                                                                                                                                                                                                                                                                              Area, duration, no. of ulcers, tissue type \[2\], ulcer type/aetiology                                             Quality of vessels \[3\]
  Meaume et al[39](#iwj13100-bib-0039){ref-type="ref"}             16                                  Age, BMI, cardiovascular disease \[2\], diabetes, DVT, gender, hypertension, musculoskeletal disease, smoking status, vascular surgery                                                                                                                                                                                                                                                                                                                                                                                                                                            Area, duration, infection, no. of ulcers, recurrent ulcer                                                          
  Moffatt et al[40](#iwj13100-bib-0040){ref-type="ref"}            23                                  Age, diabetes, DVT, gender, immobility, local physical manifestations of poor vessel quality \[4\], musculoskeletal disease \[2\]                                                                                                                                                                                                                                                                                                                                                                                                                                                 Area, duration, ulcer type/aetiology                                                                               Positive microbiology \[6\], quality of vessels \[3\]
  Parker et al[44](#iwj13100-bib-0044){ref-type="ref"}             25                                  Autoimmune disease, depression, DVT, functional status \[2\], local physical manifestations of poor vessel quality, medications as proxy for comorbidities/other health issues \[3\], musculoskeletal disease \[3\], other comorbidities and health issues, pain, socio‐economic status                                                                                                                                                                                                                                                                                           Area \[2\], duration, exudate, oedema, pain, pain, PUSH score, response to treatment, tissue type                  
  Scotton et al[47](#iwj13100-bib-0047){ref-type="ref"}            16                                  Age, antibiotics use \[2\], diabetes, gender, hypertension, immobility                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Area, duration, location, response to treatment \[2\], ulcer infection \[2\], ulcer type/aetiology                 Quality of vessels
  Taylor et al[51](#iwj13100-bib-0051){ref-type="ref"}             31                                  Age, blood pressure \[2\], BMI, cardiovascular disease, diabetes, DVT, gender, history of previous ulcers, immobility, local physical manifestations of poor vessel quality, musculoskeletal disease, smoking status, socio‐economic status                                                                                                                                                                                                                                                                                                                                       Area, duration \[2\], exudate, location, pain, surrounding skin condition \[4\], tissue type \[4\], ulcer status   Quality of vessels \[2\]
  Wipke‐Tevis and Stotts[19](#iwj13100-bib-0019){ref-type="ref"}   8                                   Gender, nutrition \[3\]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Inflammatory markers, quality of vessels \[2\], serum albumin/total protein
  Yang et al[57](#iwj13100-bib-0057){ref-type="ref"}               15                                  Age \[2\], BMI, cardiovascular disease \[3\], diabetes, DVT, gender, hypertension, musculoskeletal disease, smoking status, trauma, vascular surgery                                                                                                                                                                                                                                                                                                                                                                                                                              Area                                                                                                               

Abbreviations: BMI, body mass index; DVT, deep vein thrombosis; PUSH, pressure ulcer score for healing.

Empty cells mean that no potential factors were identified.

Medications negatively affecting ulcer healing include steroids, immunomodulating drugs, and anti‐coagulants known to prolong bleeding time.

Local physical manifestations of poor vessel quality include clinical findings such as lipodermatosclerosis, varicose eczema, hyperpigmentation, etc.

PUSH score which uses ulcer characteristics to provide a score between 0 and 10.

### 3.2.1. Patient characteristics {#iwj13100-sec-0009}

In the 36 studies investigating patient characteristics, age was investigated as a possible prognostic factor in 31 studies (11 in diabetic foot ulcers, 14 in venous leg ulcers, and 9 in pressure ulcers). This was the most commonly investigated factor, followed by gender, which was considered in 30 studies. Most studies considered age a continuous variable, whereas one used categories.[20](#iwj13100-bib-0020){ref-type="ref"} Socio‐economic status (eg, marital status, educational level, home ownership) was considered in 10 studies. The three comorbidities most commonly investigated as a potential prognostic factor were diabetes (23/42: 7 diabetic foot, 10 venous leg, and 5 pressure ulcer studies); cardiovascular disease (17/42); and musculoskeletal disease (16/42). The subcategory of diabetes was defined homogeneously as most studies discussed diabetes as a dichotomous variable, labelling patients as diabetic or not. However, cardiovascular disease contained angina (n = 2), peripheral arterial disease (n = 6), and several other conditions grouped under this subcategory. Musculoskeletal disease was also very heterogeneous, with rheumatoid arthritis (n = 6) being the most common factor in this subcategory. Other patient characteristics investigated as possible prognostic factors included: smoking status (15/42), history of deep vein thrombosis (DVT; 13/42), body mass index (BMI; 13/42), and immobility (12/42). While smoking status and history of DVT were defined relatively homogeneously across studies (mostly as current smoker yes/no and prior DVT yes/no), immobility contained many definitions, from walking aid use to paralysis; BMI was considered either a continuous or categorical variable with different categories across studies.

### 3.2.2. Ulcer characteristics {#iwj13100-sec-0010}

Ulcer characteristics were the most commonly investigated potential prognostic factor (39/42). Overall, 14, 15, and 10 studies investigated the association of at least one ulcer characteristic with the healing of diabetic foot ulcers, venous leg ulcers, and pressure ulcers, respectively. Across ulcer types, the size of the ulcer area was most frequently reported (33/42). Most studies (26/42) defined ulcer areas as the complete area of the ulcer in centimetres squared at baseline (ie, time of the first assessment), with only some studies using a different definition (eg, 90% area reduction in area at 4 weeks[48](#iwj13100-bib-0048){ref-type="ref"} or area change in first 2 weeks[33](#iwj13100-bib-0033){ref-type="ref"}). Duration of ulcer at baseline (mostly reported in days and used as a continuous variable in the models) was the next most reported factor (17/42 studies), followed by ulcer location (14/42). However, ulcer location had a number of definitions, and no single definition was used across 10 or more studies; for example, 1 study[29](#iwj13100-bib-0029){ref-type="ref"} considered which side of the body the ulcer was, while others[22](#iwj13100-bib-0022){ref-type="ref"} used the categories of toe ulcer or foot ulcer.

### 3.2.3. Results of clinical investigations {#iwj13100-sec-0011}

A total of 23 studies considered the results of clinical investigations a possible prognostic factor for ulcer healing, with 13 of these concerned the assessments of vessel quality (eg, through imaging tests). However, this was very homogeneous and included a variety of investigations for vessel quality (eg, transcutaneous oxygen pressure, skin perfusion pressure, and ankle‐brachial index). Abbade et al[20](#iwj13100-bib-0020){ref-type="ref"} considered results from seven imaging tests possible prognostic factors. Other results from clinical investigations included serum albumin (8/42), serum haemoglobin (7/42), glycaemic control (eg, HAb1C) (7/42), and renal function (eg, estimated glomerular filtration rate) (5/42). Only two studies investigated microbiology clinical investigations.[40](#iwj13100-bib-0040){ref-type="ref"}, [54](#iwj13100-bib-0054){ref-type="ref"}

4. DISCUSSION {#iwj13100-sec-0012}
=============

4.1. Summary of findings {#iwj13100-sec-0013}
------------------------

We conducted a scoping review and identified a body of literature investigating potential prognostic factors for healing of venous leg ulcers, diabetic foot ulcers, and pressure ulcers that could be assessed in routine care settings. We included 42 papers, from which we identified age, gender, smoking status, diabetes, musculoskeletal disease, cardiovascular disease, immobility, ulcer area, ulcer location, ulcer duration at time of first assessment, and vessel quality as the factors that were most often investigated as a potential prognostic factor for ulcer healing. Of these, we selected those that were defined sufficiently homogeneously across studies in order to be investigated in a future systematic review and meta‐analysis; all selected factors are listed under "Recommendations for future research" below.

4.2. Relation to other studies {#iwj13100-sec-0014}
------------------------------

Parker et al[15](#iwj13100-bib-0015){ref-type="ref"} conducted a literature review in 2015 on risk factors for delayed healing in venous leg ulcers, including 27 papers published between 2000 and 2013. Our review updates their work while extending search terms for prognostic factors in line with Cochrane guidance (<http://handbook-5-1.cochrane.org/>) and broadening the scope to include two additional prevalent ulcer types: diabetic foot and pressure ulcers. There were several studies in Parker\'s review that were captured in our search but did not meet our inclusion criteria. The main reasons for excluding these papers were: ineligible population (ie, also including people with arterial ulcers), ineligible study design (randomised control trial), ineligible publication type (literature review), or analysing effectiveness of an intervention. Parker\'s review identified ulcer area, ulcer duration, DVT, and history of previous ulcers as consistently reported risk factors for healing. The former three factors were also identified by our review, which suggests that they might have prognostic value across ulcer types.

4.3. Recommendations for future research {#iwj13100-sec-0015}
----------------------------------------

Age, gender, diabetes, smoking status, history of DVT, ulcer area, and ulcer duration at time of first assessment were investigated in a substantial number of studies, with definitions being sufficiently homogeneous. These potential prognostic factors therefore each warrant a dedicated systematic review and meta‐analysis. Effect sizes of each factor may vary between ulcer types; applying meta‐regression[60](#iwj13100-bib-0060){ref-type="ref"} would adjust for this. Another option would be to address each ulcer type in a separate meta‐analysis, but this would reduce statistical power. However, there is probably sufficient similarity between ulcer types to warrant a meta‐analysis that pools the results across types, thus increasing statistical power. Individual patient data meta‐analyses[61](#iwj13100-bib-0061){ref-type="ref"} are recommended as the gold standard for reducing heterogeneity and standardisation of definitions, but this will require access to individual patient data of all included studies, which is known to be difficult. Access to individual patient data would also allow access to raw data and not rely on categories used in the studies, which would open up possibilities to investigate additional factors in a meta‐analysis, such as BMI.

Many studies included in our review had short follow‐up times and small sample sizes, which will negatively affect the precision of the individual study effect sizes for the potential prognostic factors. Future meta‐analyses will increase this precision by combining evidence across studies into a single combined estimate of prognostic effect size, which will contribute to a better understanding of prognostic factors for ulcer healing. However, the robustness of findings from meta‐analyses investigating prognostic factors depends on the quality and risk bias of included studies,[17](#iwj13100-bib-0017){ref-type="ref"} and future systematic reviews and meta‐analyses would need to assess this, for example, using the Quality in Prognostic studies (QUIPS) tool.[62](#iwj13100-bib-0062){ref-type="ref"}

Results from clinical investigations may have prognostic value for ulcer healing, but the current evidence in observational studies is too scarce to warrant systematic reviews in this area. Therefore, future research may focus on conducting larger cohort studies investigating the association between results from clinical investigation and ulcer healing. While we excluded comparative effectiveness studies, a recent Cochrane review[63](#iwj13100-bib-0063){ref-type="ref"} included RCTs to investigate the prognostic value of protease for the healing of venous leg ulcers, resulting in the inclusion of 11 studies for meta‐analysis. A hierarchical approach or down‐weighting of observational data through the use of a power prior would be advised[64](#iwj13100-bib-0064){ref-type="ref"} in this circumstance.

4.4. Strengths and limitations of this review {#iwj13100-sec-0016}
---------------------------------------------

To our knowledge, this scoping review is the first to investigate potential prognostic factors across the most common ulcer types. We used rigorous and transparent methods, including a reproducible search strategy; duplicate assessment of articles for relevance independently by two authors, and use of a pre‐determined data extraction template. A recent study[65](#iwj13100-bib-0065){ref-type="ref"} assessing the methodological quality of 494 scoping reviews found that only 22% reported a search strategy, 36% had used two reviewers, and 43% had a data extraction template.

Our scoping review also has limitations. We did not consult stakeholders as the last phase of the review process.[66](#iwj13100-bib-0066){ref-type="ref"} This may have resulted in additional relevant studies being missed. In addition, we excluded studies on the potential prognostic value of genetic factors because they are currently difficult to include in routine ulcer assessments. Future scoping reviews should investigate this further as soon as simple genetic tests become available.

5. CONCLUSION {#iwj13100-sec-0017}
=============

Age, gender, diabetes, smoking status, ulcer area, ulcer location, and ulcer duration at time of first assessment are potential prognostic factors that warrant a systematic review and meta‐analysis to quantify their value for predicting delayed healing of common non‐traumatic skin ulcers during routine assessment. This will contribute to optimising our understanding of ulcer healing and provide valuable information for clinical practice and guidelines.
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